FDA Approves Teva's Generic Version of EpiPen Injector - WSJ
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
US FDA accepts Teva-MedinCell's NDA for drug to treat schizophrenia
A determined FDA takes down Teva's blockbuster | Evaluate
With Teva struggling, FDA warns of further shortage of Adderall
Teva Pharmaceuticals USA, Inc. news and information | American Pharmacy News
Teva's Key Drugs in Its Specialty Products Pipeline
Teva recalls seizure drug | Fierce Pharma
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
Teva Pursues Regulatory Approval in Japan for MS Drug Copaxone
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Teva entered the FDA's shame list
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
Teva tumbles as sales and earnings underwhelm
FDA clears Teva's tardive dyskinesia drug Austedo - PMLiVE
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
Teva puts the brakes on troubled California sterile injectables plant: reports | Fierce Pharma
Teva Pharmaceutical, Owner of Frazer's Cephalon, Forms Joint Venture With Japanese Drug Firm
Teva subsidiary opens $100m manufacturing facility in Croatia
Teva Seeking FDA OK to Make Generic of Firdapse for LEMS | But Therapy Maker Catalyst Vows to Enforce Its Property Rights | Lambert-Eaton News
Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko - Pharmaceutical Technology
Teva faces US marketing investigation - PMLiVE
Teva Pursues Regulatory Approval in Japan for MS Drug Copaxone
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma
Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal
Teva® Announces the Arrival of its Latest Collection for Fall 2022
Teva files potential blockbuster migraine drug for FDA approval
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
